...
首页> 外文期刊>Experimental & Molecular Pathology >Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.
【24h】

Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.

机译:蛋白酶体抑制剂在酒精性肝病大鼠模型中上调肝脏抗氧化酶。

获取原文
获取原文并翻译 | 示例

摘要

Oxidative stress occurs in the liver of rats fed with alcohol chronically due to ethanol metabolism by CYP2E1, causing liver injury. The proteasome is considered as an antioxidant defense in the cell because of its activity in removing damaged and oxidized proteins, but a growing body of evidence shows that proteasome inhibitor treatment, at a non toxic low dose, provides protection against oxidative stress. In the present study, rats were fed with ethanol for 4 weeks and were treated with the proteasome inhibitor PS-341 (Bortezomib, Velcade(R)). Exposure to proteasome inhibitor elicited the elevation of antioxidative defense by enhancing the levels of mRNA and protein expression transcripts of glutathione reductase (GSR), glutathione synthetase (GSS), glutathione peroxidase 2 (GPX2), and superoxide dismutase 2 (SOD2) in the liver of rats fed with ethanol chronically, while ethanol alone did not increase these genes' mRNA. Our results also showed that glutamate cysteine ligase catalytic subunit (GCLC), a rate-limiting enzyme in glutathione biosynthesis, was also up regulated in the liver of rats fed with ethanol and injected with PS-431. Nrf2 mRNA level was significantly decreased in the liver of ethanol fed rats, as well as in the livers of animal fed with ethanol and treated with proteasome inhibitor, indicating that the mechanism by which proteasome inhibitor up regulates the antioxidant response element is not due to regulation of Nrf2. However, ATF4, a major regulator of antioxidant response elements, was significantly up regulated by proteasome inhibitor treatment. The beneficial effects of proteasome inhibitor treatment also reside in the reversibility of the drug because the proteasome activity was significantly increased 72 h post treatment. In conclusion, proteasome inhibitor treatment used at a non toxic low dose has potential protective effects against oxidative stress due to chronic ethanol feeding.
机译:由于乙醇通过CYP2E1代谢,长期用酒精喂养的大鼠的肝脏中发生氧化应激,从而引起肝损伤。由于蛋白酶体具有清除受损蛋白质和氧化蛋白质的活性,因此被认为是细胞中的抗氧化剂防御剂,但是越来越多的证据表明,蛋白酶体抑制剂的低剂量无毒处理可提供抗氧化应激的保护作用。在本研究中,给大鼠喂食乙醇4周,并用蛋白酶体抑制剂PS-341(Bortezomib,Velcade)治疗。蛋白酶体抑制剂的暴露通过提高肝脏中谷胱甘肽还原酶(GSR),谷胱甘肽合成酶(GSS),谷胱甘肽过氧化物酶2(GPX2)和超氧化物歧化酶2(SOD2)的mRNA和蛋白质表达转录水平而引起抗氧化防御的提高。长期用乙醇喂养的大鼠中,单靠乙醇并不能增加这些基因的mRNA。我们的研究结果还表明,谷胱甘肽半胱氨酸连接酶催化亚基(GCLC)是谷胱甘肽生物合成中的限速酶,在饲喂乙醇并注射PS-431的大鼠肝脏中也被上调。 Nrf2 mRNA水平在以乙醇喂养的大鼠的肝脏中以及以乙醇喂养并用蛋白酶体抑制剂处理的动物的肝脏中均显着降低,表明蛋白酶体抑制剂上调抗氧化反应元件的机制不是由于调节Nrf2。但是,ATF4是抗氧化反应元件的主要调节剂,通过蛋白酶体抑制剂处理显着上调。蛋白酶体抑制剂治疗的有益作用还在于药物的可逆性,因为蛋白酶体活性在治疗后72小时显着增加。总之,以无毒的低剂量使用蛋白酶体抑制剂治疗具有潜在的保护作用,可防止由于长期饮酒而引起的氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号